All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

52

Reset

52 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SKB264MK-2870, Sacituzumab TirumotecanPhase 353 trials

    Merck & Co. · Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer

  • I-DXdDS-7300a, MK-2400Phase 317 trials

    Merck & Co. · Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Esophageal Squamous Cell Carcinoma

  • ZanzalintinibXL092Phase 311 trials

    Exelixis · Colorectal Cancer, Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma

  • Intismeran autogeneV940, mRNA-4157Phase 310 trials

    Merck & Co. · Non-small Cell Lung Cancer, Melanoma, Bladder Cancer

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • R-DXdDS 6000a, MK-5909Phase 310 trials

    Merck & Co. · Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer

  • FavezelimabMK-4280, MK-4820APhase 39 trials

    Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors

  • MK-2140Zilovertamab Vedotin, VLS-101Phase 39 trials

    Merck & Co. · Diffuse Large B-Cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, B-cell Acute Lymphoblastic Leukemia

  • MK-1084CalderasibPhase 38 trials

    Merck & Co. · Non-small Cell Lung Cancer, Colon Adenocarcinoma, Rectal Adenocarcinoma

  • OpevesostatMK-5684, ODM-208Phase 37 trials

    Merck & Co. · Prostate Cancer Metastatic, Malignant Neoplasm, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • MK-1045CN-201Phase 36 trials

    Merck & Co. · Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, Follicular

  • NemtabrutinibMK-1026, ARQ 531Phase 36 trials

    Merck & Co. · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma

  • Merck & Co. · Esophageal Squamous Cell Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma

  • BomedemstatMK-3543, IMG-7289Phase 35 trials

    Merck & Co. · Polycythemia Vera, Essential Thrombocythemia, Thrombocythemia, Essential

  • EnpatoranM5049, M5049 dosePhase 35 trials

    EMD Serono Research & Development Institute, Inc. · Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus

  • TiespectusEYE201, MK-8748Phase 35 trials

    EyeBiotech Ltd. · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization

  • AlimatravirMK-8527Phase 34 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, HIV

  • GocatamigHPN328, MK-6070Phase 34 trials

    Merck & Co. · Small Cell Lung Cancer, Small Cell Lung Cancer Extensive Stage, Small-Cell Lung Cancer

  • H2 receptor antagonistPhase 34 trials

    Merck & Co. · Lung Neoplasm Malignant, Esophageal Squamous Cell Carcinoma, Ovarian Cancer

  • coformulation favezelimabMK-4280APhase 33 trials

    Merck & Co. · Small Cell Lung Carcinoma, Solid Tumors, Hematologic Malignancies

  • H1 receptor antagonistPhase 33 trials

    Merck & Co. · Lung Neoplasm Malignant, Ovarian Cancer, Fallopian Tube Cancer

  • ISLPhase 33 trials

    Merck & Co. · HIV-1 Infection

  • ULOMK-8507, UlonivirinePhase 33 trials

    Merck & Co. · Human Immunodeficiency Virus Type 1 (HIV-1) Infection, HIV-1 Infection

  • VinflunineJavlorPhase 33 trials

    Merck & Co. · Bladder Cancer, Urothelial Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer

  • 2 NRTIsPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection, Infection, Human Immunodeficiency Virus, HIV Infections

  • ARTPhase 32 trials

    GSK · HIV Infections, HIV-1 Infection

  • hMGPhase 32 trials

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Infertility, Infertility (IVF Patients)

  • HS-10382MK-4208, Tern-701Phase 32 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase

  • TDFPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection

  • MolnupiravirMK-4482, LAGEVRIOPhase 31 trial

    Merck & Co. · Coronavirus Disease (COVID-19)

  • V116Phase 31 trial

    Merck & Co. · Pneumococcal Infection

  • V181Phase 31 trial

    Merck & Co. · Healthy

  • MK-4830Phase 210 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma

  • VibostolimabMK-7684Phase 26 trials

    Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma

  • MK-2010LM-299Phase 24 trials

    Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm, Malignant Tumors

  • MK-3120SKB410Phase 24 trials

    Merck & Co. · Bladder Cancer, Advanced Solid Tumors, Malignant Neoplasm

  • BoserolimabMK-5890Phase 23 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer

  • HRS-5346MK-7262Phase 23 trials

    Shandong Suncadia Medicine Co., Ltd. · Lipoprotein(a), Lipoprotein Disorder, Treatment of Lipoprotein Disorder

  • MK-0482Phase 23 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung

  • EfinopegdutideMK-6024, HM12525APhase 22 trials

    Merck & Co. · Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic

  • QuavonlimabMK-1308Phase 22 trials

    Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer

  • AGS 22M6EAGS-22CEPhase 21 trial

    Merck & Co. · Bladder Cancer

  • Merck & Co. · Small Cell Lung Carcinoma

  • DocetetaxelPhase 21 trial

    Merck & Co. · Carcinoma, Non-Small-Cell Lung

  • M5717Phase 21 trial

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection

  • MK-1200Phase 21 trial

    Merck & Co. · Advanced Solid Tumors

  • MK-1439APhase 21 trial

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection

  • MK-2214Phase 21 trial

    Merck & Co. · Early Alzheimer's Disease

  • MK-2750Phase 21 trial

    Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm

  • MK-6916Phase 21 trial

    Merck & Co. · Pain Management

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.